Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries. | Nat Commun | 2021 | 33627673 | PubTator, text mining | PubMed |
| Molecular analysis of pancreatic cystic neoplasm in routine clinical practice. | World J Gastrointest Endosc | 2021 | 33623640 | PubTator, text mining | PubMed |
| DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway. | Oncogene | 2021 | 33603168 | PubTator, text mining | PubMed |
| Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study. | BMC Gastroenterol | 2021 | 33579196 | PubTator, text mining | PubMed |
| Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis. | Int J Mol Sci | 2021 | 33572320 | PubTator, text mining | PubMed |
| Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung Cancer. | Cancers (Basel) | 2021 | 33572278 | PubTator, text mining | PubMed |
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome. | Transl Lung Cancer Res | 2021 | 33569305 | PubTator, text mining | PubMed |
| FGFR-TKI resistance in cancer: current status and perspectives. | J Hematol Oncol | 2021 | 33568192 | PubTator, text mining | PubMed |
| Characterization of Early-Onset Finger Osteoarthritis-Like Condition Using Patient-Derived Induced Pluripotent Stem Cells. | Cells | 2021 | 33557199 | PubTator, text mining | PubMed |
| TP53 Mutations as a Driver of Metastasis Signaling in Advanced Cancer Patients. | Cancers (Basel) | 2021 | 33546249 | PubTator, text mining | PubMed |
| The State-of-the-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies. | J Clin Med | 2021 | 33546207 | PubTator, text mining | PubMed |
| Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension. | Int J Mol Sci | 2021 | 33540939 | PubTator, text mining | PubMed |
| The COL11A1/Akt/CREB signaling axis enables mitochondrial-mediated apoptotic evasion to promote chemoresistance in pancreatic cancer cells through modulating BAX/BCL-2 function. | J Cancer | 2021 | 33531986 | PubTator, text mining | PubMed |
| Screening for potential targets to reduce stenosis in bioprosthetic heart valves. | Sci Rep | 2021 | 33510256 | PubTator, text mining | PubMed |
| The mutational repertoire of uterine sarcomas and carcinosarcomas in a Brazilian cohort: A preliminary study. | Clinics (Sao Paulo) | 2021 | 33503190 | PubTator, text mining | PubMed |
| Next-generation sequencing for identification of actionable gene mutations in intestinal-type sinonasal adenocarcinoma. | Sci Rep | 2021 | 33500480 | PubTator, text mining | PubMed |
| Recent Advancement in Atypical Lipomatous Tumor Research. | Int J Mol Sci | 2021 | 33498189 | PubTator, text mining | PubMed |
| Re-expression of REG family and DUOXs genes in CRC organoids by co-culturing with CAFs. | Sci Rep | 2021 | 33483567 | PubTator, text mining | PubMed |
| HEDGEHOG/GLI Modulates the PRR11-SKA2 Bidirectional Transcription Unit in Lung Squamous Cell Carcinomas. | Genes (Basel) | 2021 | 33477943 | PubTator, text mining | PubMed |
| Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward. | Ther Adv Med Oncol | 2021 | 33473249 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=52